Posts by Irene C. Souter, MD
-
New Personalized Tool Predicts Pregnancy After Ovulation Induction or Controlled Ovarian Stimulation
Using data from two multicenter, randomized trials, Irene C. Souter, MD, a fertility specialist at Massachusetts General Hospital, and colleagues created an online tool that calculates individualized probabilities of pregnancy and multiple pregnancy during each of four cycles of ovulation induction or ovarian stimulation.
-
Diagnostic Considers Antimüllerian Hormone, BMI to Predict Oligoanovulation Disorders
Irene Souter, MD, of the Fertility Center, and colleagues have created an age-adjusted model that combines serum antimüllerian hormone levels and body mass index to predict polycystic ovary syndrome and other oligoanovulation diagnoses in infertile women.
-
Exposure to Nitrogen Dioxide Increases Risk of Pregnancy Loss
Pregnancy loss associated with air pollution seems to be more common later in pregnancy, particularly after about eight weeks of gestation.
-
Male Factor Infertility Does Not Affect Duration of Pre-Implantation Embryo Development, But May Affect Usability
Male factor infertility might affect embryo usability, but regardless of severity, this diagnosis does not appear to affect duration of cleavage stages during embryo development to the blastocyst stage, as observed with time-lapse imaging.
-
Paternal Preconception Folate Intake Affects Duration of Pregnancy
Among live births achieved through assisted reproduction, higher paternal folate intake prior to conception was associated with slightly longer gestation.
-
The EARTH Study: Examining the Impact of Environment, Diet and Lifestyle on Human Reproduction
The EARTH Study is the largest of its kind, investigating the impact of more than 50 biomarkers on reproductive health through almost 20 years of continuous NIH funding.
Biography
Irene Souter, MD is an associate professor of Obstetrics, Gynecology (OB/GYN) and Reproductive Biology at Harvard Medical School. She is a reproductive endocrinologist at the Massachusetts General Hospital Fertility Center and directs the Preimplantation Genetic Diagnosis Program (PGD). She received her medical degree from the University of Athens, completed her OB/GYN residency at the University of Southern California, and her clinical fellowship in Reproductive Endocrinology and Infertility (REI) at UCLA. Prior to her residency training she completed a research fellowship at USC and pursued international medical work in South Africa.
Dr. Souter manages a high-volume clinical practice, is committed to teaching and is passionate about clinical outcomes research. Her clinical practice cares for couples with female and male infertility, and offers a wide range of treatments to include intrauterine insemination (IUI) with or without induction of ovulation, in vitro fertilization (IVF), PGD, freezing of oocytes, gamete donation and 3rd party reproduction, as well as treatments for polycystic ovary syndrome, endometriosis, recurrent pregnancy loss, congenital uterine anomalies, fibroids, and polyps. Her clinical practice is located at Mass General in Boston, MA.
Her clinical research focuses on i) clinical outcomes of ovulation induction treatments, ii) effects of the environment on reproductive health, and iii) PGD. She has co-authored numerous articles, and has delivered multiple national and international presentations. She is actively involved in the American Society for Reproductive Medicine (ASRM), the European Society for Human Reproduction and Embryology and multiple other organizations. As a member of the MGH REI Academic Faculty and in her role as the Associate Director of the REI Fellowship Program, she is very dedicated to the teaching and mentorship of OB/GYN residents and fellows.
